Cytochrome P450 2C19 (CYP2C19) genotype status is not associated with cure rates of dual therapy with rabeprazole and amoxicillin for Helicobacter pylori

Masakatsu Uchihara(Musashino Red Cross Hospital), Takahiro Sakai(Japanese Red Cross Society, Japan), Namiki Izumi(Musashino Red Cross Hospital), Jun Itakura(Musashino Red Cross Hospital), Yasuhiro Asahina(Tokyo Medical and Dental University), Kaoru Sakurai(Tokyo Medical and Dental University), Nobuhiko Kanazawa(Musashino Red Cross Hospital), Kaoru Tsuchiya(Musashino Red Cross Hospital), Shozo Miyake(Musashino Red Cross Hospital), Osamu Noguchi(Musashino Red Cross Hospital)
Gastroenterology
April 1, 2001
10.1016/s0016-5085(08)82922-8
Cited by 2

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Aryne-based strategy in the total synthesis of naturally occurring polycyclic compounds
|Chemical Society Reviews|2018|293
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)
|Hepatology Research|2023|281
Some Properties of the Products of Reaction of Tadpole Collagenase with Collagen<sup>*</sup>
|Biochemistry|1967|246